Back to Search Start Over

Comparative analysis of two arecoline‐induced oral submucous fibrosis models.

Authors :
Tang, Shijie
Jiang, Lanxin
Zhou, Ying
Zhou, Tong
Peng, Yang
Zhou, Shuting
Yue, Yuan
Xia, Xiaoqiang
Li, Jing
Chen, Qianming
Jiang, Yuchen
Feng, Xiaodong
Source :
Oral Diseases; Sep2024, Vol. 30 Issue 6, p3897-3911, 15p
Publication Year :
2024

Abstract

Objective: The limited understanding of the molecular mechanism for oral submucosal fibrosis (OSF) poses challenges to the development of effective prevention and treatment strategies. The lack of suitable animal models is a major hindrance. Therefore, this study aimed to address this issue by comparing commonly used arecoline‐induced water drinking and injection mouse models. Materials and Methods: The mice were subjected to two protocols: receiving 2 mg/mL arecoline in drinking water and 4 mg/mL arecoline saline solution injections every other day. Tissues were collected at regular 4‐week intervals, with a final time point of 20 weeks. Stereo microscopy and histomorphological analysis were performed on live and harvested tissues, respectively. Results: During arecoline treatment, collagen deposition and myofibroblast proliferation progressively increased in both models. Changes in the collagen I/III ratio indicated that both models exhibited characteristics of the early and intermediate stages of OSF after 20 weeks of arecoline induction. The water‐drinking model also demonstrated multi‐organ fibrosis involving the tongue, lungs, and small intestine. Conclusion: Both the water drinking and injection mouse models effectively induced OSF, but the water‐drinking model better mirrored the observed pathogenesis in patients with OSF. These models provide valuable tools for investigating the mechanisms underlying OSF. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1354523X
Volume :
30
Issue :
6
Database :
Complementary Index
Journal :
Oral Diseases
Publication Type :
Academic Journal
Accession number :
179392888
Full Text :
https://doi.org/10.1111/odi.14825